VistaGen TherapeuticsVTGN 
$3.36-3.72%24h
-3.72%24h
Global rank21822
Market cap$23.38M
Change 7d-5.08%
YTD Performance-33.47%
SP500 benchmarkUnderperform
P/E-0.39
P/S-102.88
Revenue-$227.30K
Earnings-$59.25M
Dividend yield-
Main Sector
Healthcare
Category
EPS for VistaGen Therapeutics (VTGN)
VistaGen Therapeutics has an EPS of $-8.50914. In 2022, the company made an earnings per share (EPS) of $-7.37925. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for VTGN
-
Value:-
EPS history for VistaGen Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$8.51 | 15.31% |
| 2022 | -$7.38 | -49.80% |
| 2021 | -$14.70 | -2.00% |
| 2020 | -$15.00 | - |
View the highest EPS stocks
